FDA grants approval of first generic naloxone nasal spray to treat opioid overdose

[Ketua Dobbs]

FDA grants approval of first generic naloxone nasal spray to treat opioid overdose

The U.S. Food and Drug Administration today granted final approval of the first generic naloxone hydrochloride nasal spray, commonly known as Narcan, a life-saving medication that can stop or reverse the effects of an opioid overdose.
Source: FDA grants approval of first generic naloxone nasal spray to treat opioid overdose